Metagenomic analysis reveals a rich bacterial content in high‐risk prostate tumors from African men.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1731, doi. 10.1002/pros.23897
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2019 AND VI 79 AND IP 15
Results: 9
1
2
Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1777, doi. 10.1002/pros.23903
- By:
- Publication type:
- Article
3
Corrigendum.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1790, doi. 10.1002/pros.23910
- Publication type:
- Article
4
CORRIGENDUM.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1789, doi. 10.1002/pros.23902
- Publication type:
- Article
5
Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1767, doi. 10.1002/pros.23901
- By:
- Publication type:
- Article
6
Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1752, doi. 10.1002/pros.23899
- By:
- Publication type:
- Article
7
Family history is significantly associated with prostate cancer and its early onset in Chinese population.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1762, doi. 10.1002/pros.23900
- By:
- Publication type:
- Article
8
Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1739, doi. 10.1002/pros.23898
- By:
- Publication type:
- Article
9
Issue Information.
- Published in:
- Prostate, 2019, v. 79, n. 15, p. 1729, doi. 10.1002/pros.23682
- Publication type:
- Article